Suppr超能文献

开发一种 STAT5 磷酸化测定法作为一种快速生物测定法,用于评估白细胞介素-7 的效力。

Development of a STAT5 phosphorylation assay as a rapid bioassay to assess interleukin-7 potency.

机构信息

Analytical Development Biotech Products, Merck KGaA, Frankfurter Str. 250, Darmstadt, Germany.

出版信息

Curr Pharm Biotechnol. 2011 Oct;12(10):1580-8. doi: 10.2174/138920111798357294.

Abstract

Interleukin (IL)-7 is a cytokine inducing the Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) pathway. As a consequence of IL-7 activating this pathway, STAT5 is phosphorylated. In pharmaceutical quality control, the potency of biopharmaceuticals is commonly assessed by proliferation assays. This is also possible for IL-7 conjugates. However, the disadvantage of these classical "endpoint-assays" is that they require very long incubation times, up to several days, since they measure the downstream events of a cellular response. As an alternative to this, we developed a rapid intracellular phosphorylation assay, measuring IL-7 induced STAT5 phosphorylation in Kit 225 cells. The Kit 225 human T cell line expresses the IL-7 receptor and is responsive to IL-7, therefore making it a good candidate cell line for assay development. Like the Kinase receptor activation (KIRA) assay, developed by Sadick et al. [1], the STAT5 phosphorylation assay was performed using two separate microtiter plates: the first one for cell stimulation and lysis, the second one for enzyme-linked immuno sorbent assay (ELISA). The assay showed a high accuracy and precision with a mean recovery of 102% and a mean coefficient of variation of 9%. In comparison to the classical proliferation assay, the phosphorylation assay is much faster. Thus, the assay procedure time can at least be reduced from six to three days by using STAT5 phosphorylation instead of proliferation as an endpoint due to the shorter incubation time with IL-7. Moreover, the phosphorylation assay shows a wider dynamic range and higher signal to noise ratios and is thus more robust than the proliferation assay.mAs a consequence, this assay could serve as reliable, accurate, precise and fast alternative to the classical proliferation assay for IL-7. This study also serves as an example for the typical steps during development and qualification / validation of a potency assay for quality control testing.

摘要

白细胞介素 (IL)-7 是一种细胞因子,可诱导 Janus 激酶 (JAK)/信号转导和转录激活因子 (STAT) 途径。由于 IL-7 激活该途径,STAT5 被磷酸化。在药品质量控制中,生物制药的效价通常通过增殖测定来评估。IL-7 缀合物也可以进行这种评估。然而,这些经典的“终点测定”的缺点是,由于它们测量细胞反应的下游事件,因此需要非常长的孵育时间,最长可达数天。作为替代方法,我们开发了一种快速的细胞内磷酸化测定法,用于测量 Kit 225 细胞中 IL-7 诱导的 STAT5 磷酸化。Kit 225 人 T 细胞系表达 IL-7 受体并对 IL-7 有反应,因此是测定开发的良好候选细胞系。与 Sadick 等人开发的激酶受体激活 (KIRA) 测定法 [1] 一样,STAT5 磷酸化测定法使用两块单独的微量滴定板进行:一块用于细胞刺激和裂解,另一块用于酶联免疫吸附测定 (ELISA)。该测定法具有很高的准确性和精密度,平均回收率为 102%,平均变异系数为 9%。与经典的增殖测定法相比,磷酸化测定法要快得多。因此,由于 IL-7 的孵育时间较短,使用 STAT5 磷酸化代替增殖作为终点,测定程序时间至少可以从六天缩短到三天。此外,磷酸化测定法具有更宽的动态范围和更高的信噪比,因此比增殖测定法更稳健。因此,该测定法可以作为 IL-7 经典增殖测定法的可靠、准确、精密和快速替代方法。本研究还为质量控制测试中效价测定的开发和资格/验证的典型步骤提供了范例。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验